These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1623840)

  • 1. [Protein C deficiency in ulcerative colitis].
    Tromm A; Hüppe D; May B
    Dtsch Med Wochenschr; 1992 Jul; 117(28-29):1130-1. PubMed ID: 1623840
    [No Abstract]   [Full Text] [Related]  

  • 2. [Acquired protein C deficiency in ulcerative colitis. The cause of thromboembolic complications].
    Korsten S; Reis HE
    Dtsch Med Wochenschr; 1992 Mar; 117(11):419-24. PubMed ID: 1347501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Thrombocytosis in ulcerative colitis and regional enteritis].
    Mohr P; Straub PW
    Schweiz Med Wochenschr; 1970 Jul; 100(27):1142-7. PubMed ID: 5524944
    [No Abstract]   [Full Text] [Related]  

  • 4. [The usefulness of reactive protein C in managing patients with ulcerative colitis and Crohn's disease].
    López Morante AJ; Sáez-Royuela F; Yuguero del Moral L; Martín Lorente JL; Ojeda Giménez C
    Rev Esp Enferm Dig; 1993 Jan; 83(1):5-9. PubMed ID: 8452705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Risk of thromboembolism in chronic inflammatory intestinal disease].
    Hüppe D; Kamp U; Krieg M; Straub H; Kuntz HD; May B
    Med Klin (Munich); 1988 Sep; 83(18):577-84. PubMed ID: 3054461
    [No Abstract]   [Full Text] [Related]  

  • 6. Thrombopoietin serum levels in patients with inflammatory bowel disease with and without previous thromboembolic events.
    Papa A; Danese S; Piccirillo N; Toriani-Terenzi C; Bartolozzi F; Piscaglia AC; Grillo A; Leone G; Gentiloni-Silveri N; Gasbarrini G; Gasbarrini A
    Hepatogastroenterology; 2003; 50(49):132-5. PubMed ID: 12630008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Endogenous toxemia in nonspecific colitis].
    Golovenko OV; Eroshkina TD; Kirkin BV; Musin II
    Sov Med; 1990; (1):67-9. PubMed ID: 2349521
    [No Abstract]   [Full Text] [Related]  

  • 8. [Decrease of antithrombin III and factor Xa inhibitor as the cause of thromboembolism complications in chronic inflammatory intestinal disease].
    Daiss W; Scheurlen M; Malchow H; Ostendorf P; Jaschonek K
    Internist (Berl); 1985 Oct; 26(10):643-5. PubMed ID: 3908368
    [No Abstract]   [Full Text] [Related]  

  • 9. Inflammatory bowel disease and leukemia.
    Cohn EM; Pearlstine B
    J Clin Gastroenterol; 1984 Feb; 6(1):33-5. PubMed ID: 6583276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homocysteine in inflammatory bowel disease: a risk factor for thromboembolic complications?
    Oldenburg B; Fijnheer R; van der Griend R; vanBerge-Henegouwen GP; Koningsberger JC
    Am J Gastroenterol; 2000 Oct; 95(10):2825-30. PubMed ID: 11051355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of venous thromboembolism and coagulation-fibrinolysis markers in Japanese patients with inflammatory bowel disease.
    Sonoda K; Ikeda S; Mizuta Y; Miyahara Y; Kohno S
    J Gastroenterol; 2004 Oct; 39(10):948-54. PubMed ID: 15549447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diseases complicating ulcerative colitis and Crohn disease].
    Mörl M
    Med Klin; 1981 Apr; 76(9):265-8. PubMed ID: 7024768
    [No Abstract]   [Full Text] [Related]  

  • 13. Determination of prothrombin activation fragments in young patients with inflammatory bowel disease.
    Smith CJ; Haire WD; Kaufman SS; Mack DR
    Am J Gastroenterol; 1996 Jun; 91(6):1221-5. PubMed ID: 8651175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
    Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [What forms of thromboembolism prevention and therapy can be used in patients with chronic inflammatory bowel diseases?].
    Seifried E; Adler G
    Internist (Berl); 1993 Jan; 34(1):67-8. PubMed ID: 8440577
    [No Abstract]   [Full Text] [Related]  

  • 16. [Thromboembolic disease in patients with ulcerative colitis. Treatment and prevention].
    Carlsen E; Evensen SA
    Tidsskr Nor Laegeforen; 1983 Sep; 103(25):1759-61. PubMed ID: 6648912
    [No Abstract]   [Full Text] [Related]  

  • 17. Malnutrition and impaired muscle strength in patients with Crohn's disease and ulcerative colitis in remission.
    Valentini L; Schaper L; Buning C; Hengstermann S; Koernicke T; Tillinger W; Guglielmi FW; Norman K; Buhner S; Ockenga J; Pirlich M; Lochs H
    Nutrition; 2008; 24(7-8):694-702. PubMed ID: 18499398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Blood level of ATP in patients with nonspecific ulcerative colitis and Crohn disease].
    Chernomordik AE; Levitan MKh; Oleĭnikov PN
    Sov Med; 1982; (3):98-100. PubMed ID: 7101043
    [No Abstract]   [Full Text] [Related]  

  • 19. Elevated plasma (1-->3)-beta-D-glucan, a fungal cell wall constituent, in a subgroup of Crohn disease.
    Chiba M; Mikami K; Iizuka M; Yukawa M; Watanabe S; Takazoe M; Fukushima T; Koganei K; Kishibe T
    Scand J Gastroenterol; 2001 Apr; 36(4):447-8. PubMed ID: 11336174
    [No Abstract]   [Full Text] [Related]  

  • 20. [Serum mucoproteins in patients with nonspecific ulcerative colitis and Crohn's disease].
    Levitan MKh; Dovgun LM; Ilysheva GN; Chernomordik AE; Ksenofontov BS
    Sov Med; 1980; (7):19-22. PubMed ID: 7256382
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.